Literature DB >> 10443829

Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis.

C O Nathan1, S Franklin, F W Abreo, R Nassar, A de Benedetti, J Williams, F J Stucker.   

Abstract

OBJECTIVE: The translation initiation factor eIF4E (4E) when overexpressed in mammalian cells results in their oncogenic transformation. 4E facilitates the synthesis of two powerful tumor angiogenic factors (VEGF and FGF-2) by selectively enhancing their translation. 4E is overexpressed not only in all head and neck squamous cell cancers but also in some dysplastic margins. Tumorigenesis in the head and neck is proposed to be a multistep process preceded by clinically evident precancerous lesions. Molecular events underlie the histological changes that herald transformation. We wanted to study the role of 4E in tumorigenesis and further elucidate its causal role in angiogenesis.
METHODS: An immunohistochemical analysis with antibodies to 4E, VEGF, and basic (b)-FGF was performed on 115 specimens of the head and neck representing various stages of histological progression of malignancy. This was correlated with mean vessel density (MVD) using factor VIII.
RESULTS: There were 41 cases of hyperplasia and low-grade dysplasia, 40 cases of high-grade dysplasia and 34 cases of cancer. There was a significant increase in the percent of cases expressing 4E from low-grade dysplasia through tumor. However, for VEGF and b-FGF the significant increase was only seen between the tumor group and dysplastic groups and no significant increase was noted between low-grade and high-grade dysplasia There was a significant increase in MVD from low- (10.7+/-1) to high-grade grade dysplasia (18.0+/-2.3). This increase was even more striking for the 4E positive cases.
CONCLUSION: 4E elevation is correlated with progressive cell transformation in the head and neck. Its correlation with VEGF, b-FGF, and MVD potentiates its possible role in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443829     DOI: 10.1097/00005537-199908000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; P E Thorpe; R A Brekken; S Konstantinos; G Fountzilas; K C Gatter; A L Harris
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.

Authors:  W K Miskimins; G Wang; M Hawkinson; R Miskimins
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Identification and Characterization of Oncogenic SOS1 Mutations in Lung Adenocarcinoma.

Authors:  Diana Cai; Peter S Choi; Maya Gelbard; Matthew Meyerson
Journal:  Mol Cancer Res       Date:  2019-01-11       Impact factor: 5.852

Review 4.  Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

Authors:  Jerry Pelletier; Jeremy Graff; Davide Ruggero; Nahum Sonenberg
Journal:  Cancer Res       Date:  2015-01-15       Impact factor: 12.701

5.  Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients.

Authors:  Cheryl Clark; Shivang Shah; Lilantha Herman-Ferdinandez; Oleksandr Ekshyyan; Fleurette Abreo; Xiaohua Rong; Jerry McLarty; Aubrey Lurie; Edward J Milligan; Cherie-Ann O Nathan
Journal:  Laryngoscope       Date:  2010-06       Impact factor: 3.325

6.  Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer.

Authors:  Jian-Wei Zhu; Bao-Ming Yu; Yu-Bao Ji; Ming-Hua Zheng; Dong-Hua Li
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

7.  Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.

Authors:  M D Berger; S Stintzing; V Heinemann; D Yang; S Cao; Y Sunakawa; Y Ning; S Matsusaka; S Okazaki; Y Miyamoto; M Suenaga; M Schirripa; S Soni; W Zhang; A Falcone; F Loupakis; H-J Lenz
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

8.  Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.

Authors:  Anju George; Swarupa Panda; Devika Kudmulwar; Salma Pathan Chhatbar; Sanjeev Chavan Nayak; Harinivas Harshan Krishnan
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 9.  Targeting Mnks for cancer therapy.

Authors:  Jinqiang Hou; Frankie Lam; Christopher Proud; Shudong Wang
Journal:  Oncotarget       Date:  2012-02

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.